LGND Ligand Pharmaceuticals
Ligand Pharmaceuticals earnings company data as of 11:09 PM ET 11/17
History
1 period, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 29 Oct | EPS | 1.42 | — | — |
| Rev | $77.2M | $78.7M | — |
Insider trades
Open-market buys and sales by LGND's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $10.8M sold by 6 insiders outside a trading plan
- $25.7M sold by 3 insiders under 10b5-1 plans
-
Martine Zimmermann DirectorSale$636K 2,000 shares at $318.17 53% of stakeTraded Nov 12 Filed Nov 16
-
John W. Kozarich DirectorPlanned sale$163K 500 shares at $325.00 1.2% of stakeTraded Nov 12 Filed Nov 16
-
Jason Aryeh DirectorSale$960K 3,000 shares at $320.05 2.8% of stakeTraded Nov 10 Filed Nov 12
-
Jason Aryeh DirectorSale$90K 282 shares at $319.99 0.3% of stakeTraded Nov 4 Filed Nov 6
-
Andrew Reardon CLO & SecretaryPlanned sale$1.6M 5,000 shares at $313.22 14% of stakeTraded Nov 2 Filed Nov 4
-
Jason Aryeh DirectorSale$676K 2,111 shares at $320.30 1.9% of stakeTraded Oct 30–Nov 2 Filed Nov 3
-
Andrew Reardon CLO & SecretaryPlanned sale$1.5M 5,000 shares at $304.07 14% of stakeTraded Oct 2 Filed Oct 6
-
Martine Zimmermann DirectorSale$342K 1,200 shares at $285.00 24% of stakeTraded Sep 10 Filed Sep 14
-
Andrew Reardon CLO & SecretaryPlanned sale$1.4M 5,000 shares at $286.09 12% of stakeTraded Sep 3 Filed Sep 8
-
Octavio Espinoza CFOPlanned sale$9.2M 31,641 shares at $292.07 53% of stakeTraded Aug 12 Filed Aug 14
-
Jason Haas DirectorSale$2.1M 7,138 shares at $292.81 64% of stakeTraded Aug 12 Filed Aug 14
-
Andrew Reardon CLO & SecretaryPlanned sale$1.4M 5,000 shares at $288.99 11% of stakeTraded Aug 3 Filed Aug 4
-
Andrew Reardon CLO & SecretaryPlanned sale$1.6M 5,000 shares at $313.28 11% of stakeTraded Jul 1 Filed Jul 6
-
Stephen L. Sabba DirectorSale$545K 2,145 shares at $254.00 6% of stakeTraded Jun 16 Filed Jun 18
-
Jason Haas DirectorSale$1.7M 6,461 shares at $255.58 57% of stakeTraded Jun 12 Filed Jun 15
Also filed in the last 12 months, not counted as buying or selling: 32 option exercises, 18 share withholdings for taxes, 16 stock grants, 4 other transactions, and 1 gift.
SEC filings
Recent issuer filings from EDGAR, 14 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 7.01,8.01 | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| 8-K/A | 9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 1.01,2.01,2.03,7.01,9.01 | Filing Doc | |
| 8-K | 1.01,2.03,3.02,8.01,9.01 | Filing Doc | |
| 8-K | 1.01,8.01,9.01 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.
Further reading
As an Amazon Associate, FollowTheFilings earns from qualifying purchases.
- How to Read a Financial Report (Tracy & Tracy) View on Amazon
- Financial Statements QuickStudy Laminated Guide View on Amazon
- Financial Intelligence, Revised Ed. View on Amazon